[Updated 5:20 p.m. See below.] Having to wait for a package to arrive generally doesn’t result in severe consequences, besides perhaps a feeling of frustration.
Some deliveries, however, are... Read more »
Synthetic biology company Synthorx is laying plans for an initial public offering to raise money to advance its suite of enhanced cytokine drugs.
The San Diego-based company says it wants to... Read more »
GreatCall, the maker of the Jitterbug cellphone and other products and services for older adults, has extended its partnership with the San Francisco-based ride-hailing company Lyft to offer GreatCall customers the... Read more »
A 10-person team of researchers at the Salk Institute for Biological Studies has been awarded an eight-year, $19.2 million grant to investigate mechanisms underlying Alzheimer’s disease and aging-related cognitive decline and... Read more »
Hundreds of companies. Dozens of research institutes. Billions of dollars in economic impact.
San Diego is one of the top U.S. cities for innovation in life sciences and healthtech. Researchers and... Read more »
Serial entrepreneur Mike Grey is launching a biotech enterprise with $120 million in new funding to advance two investigational liver disease drugs—one of which he has worked to develop before.
Called... Read more »
Mitek Systems has appointed a new chief executive, the day after rejecting an $380 million takeover bid from Florida-based ASG Technologies. A letter ASG sent to Mitek’s board of directors last... Read more »
Mitek Systems, which is being targeted for takeover by a subsidiary of Elliott, billionaire Paul Singer’s activist hedge fund, has unanimously rejected its $380 million offer.
The Oct. 31 offer—rejected... Read more »
Medical device maker ResMed has agreed to acquire Minnesota-based MatrixCare, which makes software for long-term care providers, for $750 million.
San Diego’s ResMed (NYSE: RMD) announced its intention to buy... Read more »
The second-most advanced investigational drug in MEI Pharma’s four-asset portfolio is drawing attention from overseas as a potential treatment for several leukemias and lymphomas.
Japanese life sciences company Kyowa Hakko Kirin... Read more »
Software startup Cloudbeds recently relocated its 20-odd local employees from a small space in downtown San Diego to an office nearly three times the size in the same neighborhood. The company... Read more »
It took six years for Classy, a software-as-a-service company that targets nonprofit organizations looking to fundraise online, to facilitate $500 million in donations.
But the next $500 million took just 14... Read more »
Lisa doesn’t interrupt. She doesn’t mind long pauses between responses. And she has a sense of humor.
Oh – and, she’s virtual.
San Diego startup Cuida Health, a recent graduate of... Read more »
The winner of the largest-ever startup pitch contest in San Diego is aiming to solve a problem that is weighing heavily on the national consciousness.
The same day President Trump signed... Read more »
[Corrected 1:38 pm. See below.] Shares of San Diego-based Mirati Therapeutics fell 15 percent Monday as data from an ongoing mid-stage study of one of its experimental cancer drugs disappointed investors.... Read more »
Five-year-old biotech TP Therapeutics has raised an $80 million mezzanine financing round and promoted its chief medical officer, Athena Countouriotis, to CEO.
The San Diego-based biotech, which is developing targeted cancer... Read more »
Origin Code Academy, one of San Diego’s few coding schools—for-profit companies that offer short-term vocational training in computer programming—said this month it will shutter on Nov. 16 after about three years... Read more »
Reflexion Health, which has developed a “virtual physical therapy” system for patients recovering from surgery, said results from a randomized controlled clinical trial completed by nearly 300 people showed patients who... Read more »
Andrian Pawluk was living in San Diego when Teradata hired him this year and tasked him with transforming 65,000 square feet of offices into an alluring workspace for techies—but he had... Read more »
Ligand Pharmaceuticals said Wednesday that its acquisition of U.K.-based biotech Vernalis has closed.
The $42.3 million deal netted the San Diego company eight partner programs and a 70-person R&D team in... Read more »